MSB

37.95

+0.21%↑

USAU

19.35

-1.28%↓

MSB

37.95

+0.21%↑

USAU

19.35

-1.28%↓

MSB

37.95

+0.21%↑

USAU

19.35

-1.28%↓

MSB

37.95

+0.21%↑

USAU

19.35

-1.28%↓

MSB

37.95

+0.21%↑

USAU

19.35

-1.28%↓

Search

Balchem Corp

Fechado

SetorMateriais básicos

153.22 -0.8

Visão Geral

Variação de preço das ações

24h

Atual

Mín

150.23

Máximo

154

Indicadores-chave

By Trading Economics

Rendimento

2M

40M

Vendas

12M

268M

P/E

Médio do Setor

34.21

32.653

Rendimento de Dividendos

0.55

Margem de lucro

15.058

Funcionários

1,355

EBITDA

14M

77M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+13.87% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

0.55%

3.09%

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

192M

5.1B

Abertura anterior

154.02

Fecho anterior

153.22

Sentimento de Notícias

By Acuity

50%

50%

73 / 166 Ranking em Basic materials

Pontuação Técnica

By Trading Central

Confiança

Very Strong Bullish Evidence

Balchem Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

31 de dez. de 2025, 22:20 UTC

Grandes Movimentos do Mercado

Outlook Therapeutics Shares Fall After Another FDA Rejection of Macular Degeneration Drug

31 de dez. de 2025, 17:31 UTC

Grandes Movimentos do Mercado

OwlTing Climbs on Launch of $10 Million Stock-Buyback Program

31 de dez. de 2025, 16:30 UTC

Grandes Movimentos do Mercado

Trump Media Gains on Plan to Distribute Digital Tokens to Shareholders

31 de dez. de 2025, 15:19 UTC

Grandes Movimentos do Mercado

Axsome Shares Climb on FDA Fast‑Track for Alzheimer's Drug, Backing for Narcolepsy Filing

31 de dez. de 2025, 15:17 UTC

Grandes Movimentos do Mercado

Nike Shares Rise After CEO Hill Buys $1 Million of Shares

31 de dez. de 2025, 14:37 UTC

Grandes Movimentos do Mercado

Corcept Shares Fall as FDA Requires More Evidence for Hypercortisolism Drug Application

31 de dez. de 2025, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

31 de dez. de 2025, 21:13 UTC

Aquisições, Fusões, Aquisições de Empresas

10 People to Watch in Wealth Management in 2026 -- Barrons.com

31 de dez. de 2025, 20:40 UTC

Conversa de Mercado

Dollar Posting Its Worst Year Since 2017 -- Market Talk

31 de dez. de 2025, 20:22 UTC

Conversa de Mercado

Oil Posts Loss in a Year Marked By Plentiful Supply -- Market Talk

31 de dez. de 2025, 19:50 UTC

Conversa de Mercado

U.S. Natural Gas Futures Sink on Weather Outlook -- Market Talk

31 de dez. de 2025, 19:31 UTC

Conversa de Mercado

Precious Metals Cap Off Record Runs -- Market Talk

31 de dez. de 2025, 18:50 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

31 de dez. de 2025, 18:50 UTC

Conversa de Mercado

Canadian Gold Miners Enjoy a Bumper Year in 2025 -- Market Talk

31 de dez. de 2025, 17:17 UTC

Conversa de Mercado

U.S. Natural Gas Inventories Fall Less Than Expected -- Market Talk

31 de dez. de 2025, 17:16 UTC

Grandes Movimentos do Mercado

OwlTing Climbs on Launch of $10M Stock-Buyback Program

31 de dez. de 2025, 17:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

31 de dez. de 2025, 17:00 UTC

Aquisições, Fusões, Aquisições de Empresas

Nvidia Is Getting Creative as Options to Use Its Cash Flood Narrow -- Heard on the Street -- WSJ

31 de dez. de 2025, 15:57 UTC

Aquisições, Fusões, Aquisições de Empresas

Vanda Pharmaceuticals Shares Jump 30% on Motion Sickness Drug Approval -- Barrons.com

31 de dez. de 2025, 15:54 UTC

Conversa de Mercado

Layoff Data Supports Dollar at End of Losing Year -- Market Talk

31 de dez. de 2025, 15:02 UTC

Grandes Movimentos do Mercado

Nike Shares Rise After CEO Hill Buys $1M of Shares

31 de dez. de 2025, 14:40 UTC

Aquisições, Fusões, Aquisições de Empresas

Nike CEO Buys $1 Million of Stock as Insiders Bet on a Turnaround -- Barrons.com

31 de dez. de 2025, 14:20 UTC

Conversa de Mercado

Crude Futures On Track to End the Year With Losses -- Market Talk

31 de dez. de 2025, 13:46 UTC

Conversa de Mercado

U.S. Natural Gas Falls on Milder Weather Outlook -- Market Talk

31 de dez. de 2025, 13:01 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

Charles Schwab Is Back on Offense. Its Stock Is a Buy. -- Barrons.com

31 de dez. de 2025, 11:10 UTC

Conversa de Mercado

Copper Remains in Touching Distance of Record Highs -- Market Talk

31 de dez. de 2025, 10:46 UTC

Conversa de Mercado

Euro on Track For Strong Annual Performance -- Market Talk

31 de dez. de 2025, 10:25 UTC

Conversa de Mercado

European Gas Prices Rise But Remain on Track for Heavy Annual Loss -- Market Talk

31 de dez. de 2025, 10:23 UTC

Conversa de Mercado

Chinese Yuan Rises to 31-Month High Against Dollar as Policymakers -- Market Talk

31 de dez. de 2025, 09:33 UTC

Conversa de Mercado

Dollar Set For Worst Annual Performance Since 2017 -- Market Talk

Comparação entre Pares

Variação de preço

Balchem Corp Previsão

Preço-alvo

By TipRanks

13.87% parte superior

Previsão para 12 meses

Média 176 USD  13.87%

Máximo 190 USD

Mínimo 162 USD

Com base em 2 analistas de Wall Street que oferecem metas de preço de 12 meses para Balchem Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

2 ratings

1

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

157.75 / 166.25Suporte e Resistência

Curto Prazo

Very Strong Bullish Evidence

Médio Prazo

Bearish Evidence

Longo Prazo

Strong Bearish Evidence

Sentimento

By Acuity

73 / 166 Ranking em Materiais básicos

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Balchem Corp

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
help-icon Live chat